FIGURE 1 Changes in lipids and lipoproteins after consuming a Med-Red or Med-Control diet for 5 wk. Results are ... FIGURE 1 Changes in lipids and lipoproteins.

Slides:

Advertisements

Similar presentations

J Exp Bot. 2017;68(17): doi: /jxb/erx352

Advertisements

Serum Cholesterol levels mg/dl Frequency P

Figure 1: Necrobiosis lipoidica: Yellow-brown skin lesions with indurated borders located on both lower legs. Figure 1: Necrobiosis lipoidica: Yellow-brown.

Figure 1. Overview of the workflow of NetworkAnalyst 3.0.

Figure 1 The study area within Vienna Zoo is outlined in red

Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.

Figure 1 Top: Annual modal paternity distance (PDc) estimated for each of 23 cohorts by MasterBayes ... Figure 1 Top: Annual modal paternity distance (PDc)

FIGURE 1 Association of habitual coffee intake with incident of CVD in the UK Biobank and in an earlier meta-analysis ... FIGURE 1 Association of habitual.

Figure 1: Axial T2 W images of penis showed a well-defined septated area of 2 cm in the posterior aspect of ... Figure 1: Axial T2 W images.

FIGURE 1 Histological diagnoses divided into 8-year time frames (n = 1208). Unless provided in the caption above, the following copyright applies to the.

FIGURE 1 The effect of daprodustat on hemoglobin (Hgb) levels

Figure 1 The process of bone defect creation, implant insertion and ridge augmentation. (a) Creation of standardized ... Figure 1 The process of bone defect.

FIGURE 1 Percentage of patients with sarcopenia or low SMD across the spectrum of total adiposity (N = 3262). SMD, ... FIGURE 1 Percentage of patients.

FIGURE 2 Responses to the question: regarding vasoactive drugs, does your centre use the following frequently, rarely ... FIGURE 2 Responses to the question:

FIGURE 1 Maternal (A) urinary aldosterone; (B) plasma active renin; (C) urinary AGT concentrations; and (D) plasma AGT ... FIGURE 1 Maternal (A) urinary.

FIGURE 1 Patient enrolment flowchart. SBS, short bowel syndrome.

FIGURE 1 α-Diversity comparisons of gut microbiota from DM and MOM infants by age and antibiotic exposure. Using ... FIGURE 1 α-Diversity comparisons of.

Figure 1. Ratios of observed to expected numbers of exon boundaries aligning to boundaries of domain and disorder ... Figure 1. Ratios of observed to expected.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.

Figure 1. Comparison of weighted estimates of diarrhoea prevalence in children under five by country between PMA Figure 1. Comparison of weighted.

Fig. 1 Kaplan-Meier plot of cumulative incidence of cancer onset following dermatomyositis diagnosis stratified ... Anti-TIF1-Ab: anti-transcriptional.

Fig. 1 Mean change from baseline in ANC ± s. e

Point estimates with ... Point estimates with 95% CI. HR: hip replacement; KR: knee replacement. Unless provided in the caption above, the following copyright.

FIGURE 1 Analytic framework for systematic reviews on types and amounts of CFBs consumed and growth, size, and body ... FIGURE 1 Analytic framework for.

FIGURE 1 Participant flow diagram. Exercise Counseling Clinic (ECC).

Graph 1. The number of homicide cases per year discussing neuro-evidence. Unless provided in the caption above, the following copyright applies to the.

Figure 2. Natural history of chlamydia transmission, with arrows showing the transitions between health states. Figure 2. Natural history of chlamydia.

Figure 1. Mean concentration–time profiles of ascending doses of ivermectin in (a) PSAC and (b) SAC. Weight-dependent ... Figure 1. Mean concentration–time.

Figure 1 Nelson-Aalen estimates of the cumulative incidence rates for patients on versus off IST. ON = optic neuritis; ... Figure 1 Nelson-Aalen estimates.

FIGURE 1 Malta: a plate-style food guide

Figure 1. A, Crude incidence rates per 100 person-years of follow-up and 95% confidence intervals for each solid organ ... Figure 1. A, Crude incidence.

FIGURE 1 Study consort diagram

Fig. 2 Case 2. Levels of serum creatinine and anti-GBM antibodies before and during treatment with cyclophosphamide, ... Fig. 2 Case 2. Levels of serum.

FIGURE 1 Food groups consumed (mean, g/d) among US infants and young children by age group and tertile of mean ... FIGURE 1 Food groups consumed (mean,

FIGURE 1 Ten-year trends in growth by diet group (human milk only, combination of human milk with formula or ... FIGURE 1 Ten-year trends in growth by.

FIGURE 1 Consolidated Standards of Reporting Trials (CONSORT) diagram for the follow-up study. Unless provided in the caption above, the following copyright.

Figure 1. The workflow of Cistrome-GO

Figure 1: Predicted probability of nest presence (0 = no nest and 1 = nest present) in response to canopy cover for ... Figure 1: Predicted probability.

Figure 1. Using Voronoi tessellation to define contacts

Fig. 1. iS-CellR pipeline overview

Figure 4. RLS spectra of (A) TMPipEOPP and (B) OMHEPzEOPP in the presence of different concentrations of KRAS. The RLS ... Figure 4. RLS spectra of (A)

Figure 1. Schematic diagram of solar energy and coal-fired power generation system. Unless provided in the caption above, the following copyright applies.

Figure 1. Uncertainty reduction, value creation, and appropriation in two case studies. Unless provided in the caption above, the following copyright applies.

FIGURE 1 Predicted risk of NTDs by RBC folate concentrations by folic acid source among nonpregnant women aged 12– FIGURE 1 Predicted risk of NTDs.

Figure 1. The configuration menu allows the user to choose among the main visualization/processing options of the ... Figure 1. The configuration menu.

Figure 1. (A) Architecture of Doc2Hpo. (B) Interactive user interface

Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.

Figure 1. Overview of features that can be assessed in a single RegulationSpotter VCF analysis run. Depending upon a ... Figure 1. Overview of features.

Figure 1 Patient disposition

FIGURE 2 Stable isotope infusion protocol

Figure 2. Result page of a Primer3Plus Cloning run showing the left and right primers in blue and yellow. The included ... Figure 2. Result page of a Primer3Plus.

Figure 4. Healthcare utilization for paediatric diarrhoea by caregivers. Pyramid plot showing the number and ... Figure 4. Healthcare utilization for paediatric.

FIGURE 1 Weight loss for participants (n = 128) who consumed the high-egg (n = 66) or the low-egg (n = 62) diets ... FIGURE 1 Weight loss for participants.

Figure 1 Distribution of WCD use days in WEARIT-II

Figure 1 Correlation between en face Oil-Red O staining and aortic root lesion size vs. plasma cholesterol and ... Figure 1 Correlation between en face.

FIGURE 2 Regression of age- and sex-adjusted mean BMI (A) and WC (B) across obesity (BMI) GRSs. Black dots: age- and ... FIGURE 2 Regression of age- and.

Figure 1. Excess cost of methicillin-resistant Staphylococcus aureus (MRSA) compared with methicillin-susceptible S. ... Figure 1. Excess cost of methicillin-resistant.

Figure 1 Genetic results. No case had more than one diagnostic result

Figure 1. (A) Baseline contrast-enhanced CT scan of melanoma patient presenting with metastases in the liver and lymph ... Figure 1. (A) Baseline contrast-enhanced.

Figure 1. Prevalence of parasitic infection and anemia among the children. Unless provided in the caption above, the following copyright applies to the.

FIGURE 1 Study and analyses workflow

Figure 1. GWAS Catalog associations for coronary artery disease plotted across all chromosomes. Associations added ... Figure 1. GWAS Catalog associations.

FIGURE 1 Results for primary meta-analysis of controlled trials for the effects of walnut-enriched compared with ... FIGURE 1 Results for primary meta-analysis.

Source:Zimnisky (2014). Source:Zimnisky (2014).

Figure 1 Mechanisms of mitral regurgitation.

Figure 2. Model adequacy results for the two empirical data sets, West African Ebola, and 2009 H1N1 influenza. The ... Figure 2. Model adequacy results.

Figure 1. Unrooted phylogenetic trees for UL73 and UL74 based on amino acid sequences derived from 243 genome ... Figure 1. Unrooted phylogenetic trees.

Fig. 1. Examples of plots of NanoPlot and NanoComp

Figure 1. Hepatitis C screening and diagnostic algorithm at the MSF clinic, Karachi, Pakistan, March 2016–September ... Figure 1. Hepatitis C screening.

Figure 1. Enteropathogen prevalence in stool samples collected from 996 children in the Sanitation Hygiene Infant ... Figure 1. Enteropathogen prevalence.

Presentation transcript:

FIGURE 1 Changes in lipids and lipoproteins after consuming a Med-Red or Med-Control diet for 5 wk. Results are ... FIGURE 1 Changes in lipids and lipoproteins after consuming a Med-Red or Med-Control diet for 5 wk. Results are presented as LS means ± SEMs (n = 41). Data were analyzed using a doubly repeated-measures ANOVA adjusted for age, sex, and body mass at each time point. *Nondifferential change over time. <sup>†</sup>Differential response between Med-Red and Med-Control when intervention × time P value < 0.05. <sup>‡</sup>Intervention-specific change over time indicated by intervention × time P < 0.05. ApoB results followed a similar pattern as LDL cholesterol and are available in Supplemental Tables 1 and 2. Conversion factors are available at: http://www.amamanualofstyle.com/page/si-conversion-calculator. ApoB, apolipoprotein B; LS, least squares; Med-Control, Mediterranean-style eating pattern with ∼200 g lean, unprocessed red meat/wk; Med-Red, Mediterranean-style eating pattern with ∼500 g lean, unprocessed red meat/wk. Unless provided in the caption above, the following copyright applies to the content of this slide: © 2018 American Society for Nutrition.This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. Am J Clin Nutr, Volume 108, Issue 1, 13 June 2018, Pages 33–40, https://doi.org/10.1093/ajcn/nqy075 The content of this slide may be subject to copyright: please see the slide notes for details.

FIGURE 2 Changes in systolic blood pressures from consuming a Med-Red or Med-Control diet for 5 wk. Results are ... FIGURE 2 Changes in systolic blood pressures from consuming a Med-Red or Med-Control diet for 5 wk. Results are presented as LS means ± SEMs (n = 41). Data were analyzed using a doubly repeated-measures ANOVA adjusted for age, sex, and body mass at each time point. *Change over time. <sup>1</sup>Waking blood pressure: 0800–2100. <sup>2</sup>Sleeping blood pressure: 2230–0730. Diastolic blood pressure results followed similar patterns and are available in Supplemental Tables 1 and 2. LS, least squares; Med-Control, Mediterranean-style eating pattern with ∼200 g lean, unprocessed red meat/wk; Med-Red, Mediterranean-style eating pattern with ∼500 g lean, unprocessed red meat/wk. Unless provided in the caption above, the following copyright applies to the content of this slide: © 2018 American Society for Nutrition.This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. Am J Clin Nutr, Volume 108, Issue 1, 13 June 2018, Pages 33–40, https://doi.org/10.1093/ajcn/nqy075 The content of this slide may be subject to copyright: please see the slide notes for details.